These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30084402)

  • 1. Small Interfering RNA Targeting α-Fodrin Suppressing the Immune Response of Sjögren's Syndrome Mice.
    Sun XL; Pang CY; Liu Y; Zhang W; Wang YF
    Chin Med J (Engl); 2018 Nov; 131(22):2752-2754. PubMed ID: 30084402
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity].
    He J; Zhao JX; Wang H; Li ZG
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):625-9. PubMed ID: 18646720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
    Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
    Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren's syndrome--close to cause and cure?
    Talal N
    Adv Exp Med Biol; 1994; 350():679-82. PubMed ID: 8030555
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary Sjögren's syndrome and deficiency of ICA69.
    Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
    Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
    Park E; Kim D; Lee SM; Jun HS
    Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquaporin gene therapy corrects Sjögren's syndrome phenotype in mice.
    Lai Z; Yin H; Cabrera-Pérez J; Guimaro MC; Afione S; Michael DG; Glenton P; Patel A; Swaim WD; Zheng C; Nguyen CQ; Nyberg F; Chiorini JA
    Proc Natl Acad Sci U S A; 2016 May; 113(20):5694-9. PubMed ID: 27140635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to the amino-terminal fragment of beta-fodrin expressed in glandular epithelial cells in patients with Sjögren's syndrome.
    Kuwana M; Okano T; Ogawa Y; Kaburaki J; Kawakami Y
    J Immunol; 2001 Nov; 167(9):5449-56. PubMed ID: 11673564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice.
    Hayakawa I; Tedder TF; Zhuang Y
    Immunology; 2007 Sep; 122(1):73-9. PubMed ID: 17472721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
    Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
    Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against alpha-fodrin in Sjögren's syndrome.
    Ulbricht KU; Schmidt RE; Witte T
    Autoimmun Rev; 2003 Mar; 2(2):109-13. PubMed ID: 12848967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifodrin antibodies in Sjogren's syndrome: a review.
    Witte T
    Ann N Y Acad Sci; 2005 Jun; 1051():235-9. PubMed ID: 16126964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathogenesis of Sjögren's syndrome.
    Moutsopoulos HM
    Isr J Med Sci; 1988 Dec; 24(12):737-9. PubMed ID: 3066783
    [No Abstract]   [Full Text] [Related]  

  • 14. Highlights of the 14th International Symposium in Sjögren's Syndrome.
    Bombardieri M; Baldini C; Alevizos I; Akpek E; Baer AN
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):3-13. PubMed ID: 30156541
    [No Abstract]   [Full Text] [Related]  

  • 15. BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation.
    Ding J; Zhang W; Haskett S; Pellerin A; Xu S; Petersen B; Jandreski L; Hamann S; Reynolds TL; Zheng TS; Mingueneau M
    Clin Immunol; 2016 Aug; 169():69-79. PubMed ID: 27352977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulation of lacrimal gland output: a tear jet for replacing eye moisture in Sjögren's syndrome.
    Bertera JH
    Adv Exp Med Biol; 1994; 350():577-82. PubMed ID: 8030538
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies to alpha-fodrin derived peptide in Sjögren's syndrome.
    He J; Chen QL; Li ZG
    Ann Rheum Dis; 2006 Apr; 65(4):549-50. PubMed ID: 16531552
    [No Abstract]   [Full Text] [Related]  

  • 18. Sjögren's syndrome: immunological response underlying the disease.
    Brayer JB; Humphreys-Beher MG; Peck AB
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):353-60. PubMed ID: 11798133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to alpha-fodrin in primary Sjögren's syndrome and SLE detected by an in vitro transcription and translation assay.
    Nordmark G; Rorsman F; Rönnblom L; Cajander S; Taussig MJ; Kämpe O; Winqvist O
    Clin Exp Rheumatol; 2003; 21(1):49-56. PubMed ID: 12673889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of Sjögren's syndrome models by immunization with alpha-Fodrin: experiment with mice].
    He J; Wang H; Zhao JX; Li ZG
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2360-3. PubMed ID: 19087701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.